Vitamin D receptor gene polymorphisms in nephrotic syndrome children

Authors

  • Gamila S.M. El-Saeed Department of Medical Biochemistry, National Research Centre, Cairo, Egypt
  • Manal F. Elshamaa Department of Pediatrics, National Research Centre, Cairo, Egypt
  • Hanan Abdelaziz Department of Pediatrics, Faculty of Medicine, Cairo University, Egypt
  • Eman A. Elghoroury Department of Clinical and Chemical Pathology, National Research Centre, Cairo, Egypt
  • Safaa M. Abdelrahman Department of Pediatrics, Faculty of Medicine, Cairo University, Egypt
  • Dalia A. Abdelhalim Department of Clinical and Chemical Pathology, National Research Centre, Cairo, Egypt
  • Mona H. Ibrahim Department of Clinical and Chemical Pathology, National Research Centre, Cairo, Egypt
  • Eman M. Hassan Department of Clinical and Chemical Pathology, National Research Centre, Cairo, Egypt
  • Marwa M. Nabhan Department of Pediatrics, Faculty of Medicine, Cairo University, Egypt

DOI:

https://doi.org/10.56511/JIPBS.2018.v5.i04.pp86-93

Abstract

Background: Vitamin D mechanism of action is organized by vitamin D receptors (VDRs), which are affected by diverse genetic polymorphisms, comprising FokI, ApaI, TaqI and BsmI restriction fragment length polymorphisms. It has been declared to be associated with several diseases. The aim of our study was to define the frequency and the association of VDR gene polymorphic variants in Egyptian children with nephrotic syndrome (NS). Subjects and methods: This study included 93 children classified as 50 children with nephrotic syndrome and 43 healthy children as control subjects. The four VDR polymorphic sites (FokI, ApaI, TaqI and BsmI) were genotyped by polymerase chain reaction-restriction fragment length polymorphism (RFLP) in EDTA blood. Serum vitamin D (25(OH)D3), parathyroid hormone (PTH), intact parathyroid hormone (iPTH) and fibroblast growth factor-23 (FGF-23) concentrations were assayed by ELISA (enzyme linked immunosorbent assay). Results: Genotype and allele frequencies were compared among nephrotic syndrome patients and controls. There was no significant difference (p>0.05) at three polymorphic sites FokI, ApaI and TaqI, except at BsmI a significant correlation was observed (P=0.013). There was significant correlation between ApaI and albumin /creatinine (p=0.016) in NS. Vitamin D and PTH levels were significantly lower in NS than controls (p=0.001) and (p=0.006) respectively, where iPTH and FGF-23 levels were significantly higher in NS (p=0.002) and (p=0.047) respectively. There were significant variances in the frequency of four-marker haplotype alleles in NS cases and controls. Conclusion: Our results revealed that BsmI VDR gene polymorphism may have a significant role in children having nephrotic syndrome

Keywords:

Nephrotic syndrome, Vitamin D Receptor, Gene polymorphism, Genotyping

Downloads

Download data is not yet available.

References

Bakkaloglu SA, Schaefer F. Diseases of the kidney and urinary tract in children. In: Taal MW, Chertow GM, Marsden PA, et al., eds. Brenner and Rector’s The Kidney . 9th ed. Philadelphia: Saunders; 2011: 2622 – 2643.

Hossain MA, Deb KP, Hossain MA, Mannan KA, Mostafa G and Hossain MM:Correlation between Serum Cholesterol and Serum Albumin Level in Childhood Nephrotic Syndrome. Urology & Nephrology Open Access Journal 2016; 3(4):00086

Nigwekar S. U., Tamez H. and Thadhani R.:Vitamin D and chronic kidney disease – mineral bone disease (CKD – MBD). BoneKEy Reports; 3, Article number:498, BoneKEy Reports ISSN (online): 2047-6396 © 2017. International Bone & Mineral Society (2014).

Bouillon , Carmeliet R, Verlinden G, Etten L, Verstuyf E, Luderer A, et al.: Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice. Endocr. Rev. 2008; 29(6): 726 – 776.

Byers SW, Rowlands T, Beildeck M, Bong YS: Mechanism of action of Vitamin D and the Vitamin D receptor in colorectal cancer prevention and treatment. Rev. Endocr. Metab. Disord. 2012; 13(1):31 – 38.

Bikle DD: Vitamin D metabolism, mechanism of action, and clinical applications. Chem. Biol. 2014; 21(3):319 – 329.

Uitterlinden AG, Fang Y, van Meurs JB, van Leeuwen H, Pols HA:Vitamin D receptor gene polymorphism in relation to Vitamin D related disease states. J. Steroid Biochem. Mol. Biol. 2004; 89 – 90(1 – 5):187 – 193. [ PubMed ].

Melhus H, Kindmark A, Amér S, Wilén B, Lindh E, Ljunghall S: Vitamin D receptors genotype in osteoporosis. Lancet 1994; 344(8927):949 – 950. [ PubMed ].

Gunes S, Bilen CY, Kara N, Asci R, Bagci H, Yilmaz AF:Vitamin D receptor gene polymorphism in patients with urolithiasis. Urol. Res. 2006; 34(1):47 – 52.

Lin NU, Malloy PJ, Sakati N, al-Ashwal A, Feldman D: A novel mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor causes hereditary 1, 25-dihydroxyvitamin D-resistant rickets. J. Clin. Endocrinol. Metab.1996; 81(7):2564 – 2569.

Seyhan S, Yavascaoglu I, Kilicarslan H, Dogan HS, Kordan Y: Association of vitamin D receptor gene Taq I polymorphism with recurrent urolithiasis in children. Int. J. Urol. 2007; 14(12):1060 – 1062.

Cooper JD, Smyth DJ, Walker NM, et al.: Inherited variation in Vitamin D gene is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 2011; 60(5):1624 – 163.

Speer G, Cseh K, Winkler G, et al.: Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. Eur Endocrinol. 2001; 144(4):385 – 389.

Calle C, Maestro B, Garcia-Arencibia M.: Genomic actions of 1, 25dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats. BMC Mol Biol. 2008; 9:65.

Peacock M, Turner CH, Econs MJ, Foroud T: Genetics of osteoporosis. Endocr. Rev. 2002; 23: 303-326.

BodokiL, ChenJ, Zeher M, Nagy-Vincze M,Griger Z, Zilahi E, and Dankó K: Vitamin D Receptor Gene Polymorphisms and Haplotypes in Hungarian Patients with Idiopathic Inflammatory Myopathy. BioMed Research International 2015; Article ID 809895, 8 pages.

ChanYH: Biostatistics 102: Quantitative Data-Parametric & Nonparametric Tests. Singapore Med J. 2003a; 44(8): 391-396.

Chan YH: Biostatistics 104: Correlational Analysis. Singapore Med. J. 2003b; 44(12):614-619.

Chan YH: Biostatistics 202: logistic regression analysis. Singapore Med. J. 2004; 45(4): 149-153.

Yousefzadeh P, Shapses SA and Wang X: Vitamin D Binding Protein Impact on 25-Hydroxyvitamin D Levels under Different Physiologic and Pathologic Conditions. International Journal of Endocrinology 2014; Article ID 981581, 6 pages.

Doorenbos CR, de Cuba MM, Vogt L, KemaIP, van den Born J, Gans RO, et al.: Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease. Journal of Steroid Biochemistry and Molecular Biology 2012; 128(1-2): 56 – 61.

Mirkovic´ K, Doorenbos CRC, Dam WA, Lambers Heerspink HJ, Slagman MCJ, et al.: Urinary vitamin D binding protein: A potential novel marker of renal interstitial inflammation and fibrosis. PLoS ONE 2013; 8(2): e55887.

Blanton, HanD, Bierschenk Z, et al.: Reduced serum vitamin D-binding protein levels are associated with type 1 diabetes. Diabetes 2013; 60(10): 2566 – 70.

Stokes, Volmer C S, Grünhage D A and Lammert F: Vitamin D in chronic liver disease. Liver International 2013; 33(3): 338 – 352.

Denburg, Kalkwarf M R, de Boer H J, Hewison I H, Shults M, Zemel J, et al.: Vitamin D bioavailability and catabolism in pediatric chronic kidney disease. Pediatric Nephrology 2013; 28(9):1843-53.

CarpenterTO, ZhangJH, Parra E, EllisBK, Simpson C, Lee WM, et al.: Vitamin D binding protein is a key determinant of 25-hydroxyvitamin D levels in infants and toddlers. Journal of Bone and Mineral Research 2013; 28(1):213 – 221.

Blanton D, Han Z, Bierschenk L, Linga-Reddy MV, Wang H, ClareSalzler M, et al.: Reduced serum vitamin D-binding protein levels are associated with type 1 diabetes. Diabetes 2011; 60(10): 2566 – 70.

Jassil NK, Sharma A, Bikle D, Wang X: Vitamin D binding protein and 25-hydroxyvitamin D levels: Emerging clinical applications. Endocr. Pract. 2017; 23(5): 605-13.

Pereira RC, Juppner H, Azucena-Serrano CE, Yadin O, Salusky IB, Wesseling-Perry K: Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease. Bone 2009; 45(6): 1161-68.

Filler G, Liu D, Huang SH, Casier S, Chau LA, Madrenas J.: Impaired GFR is the most important determinant for FGF-23 increase in chronic kidney disease. Clin. Biochem. 2011; 44(5-6): 435-437.

Yasin A, Liu D, Chau L, Madrenas J and Filler G: Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study.BMC Nephrology 2013;14:39.

Shih-Ping Ch, Chien-Liang L, Tsang-Pai L, Yi-Chiung H and Jie-Jen L: Association between Parathyroid Hormone Levels and Inflammatory Markers among US Adults. Mediators of Inflammation 2014; Article ID 709024, 8 pages.

Byers SW, Rowlands T, Beildeck M, Bong YS: Mechanism of action of Vitamin D and the Vitamin D receptor in colorectal cancer prevention and treatment. Rev. Endocr. Metab. Disord. 2012; 13(1):31 – 38.

Al-Eisa AA and Haider MZ: Vitamin D receptor gene TaqI and Apal polymorphisms and steroid responsiveness in childhood idiopathic nephrotic syndrome. Int. J. Nephrol. Renovasc. Dis. 2016; 9: 187 – 192.

Yang L, Wu L, Fan Y, Ma J: Associations Among Four Polymorphisms (BsmI, FokI, TaqI and ApaI) of Vitamin D Receptor Gene and End-stage Renal Disease: A Meta-Analysis. Archives of Medical Research 2015; 46 (2):172.

Mathieson PW: Cytokine polymorphisms and nephrotic syndrome. Clin Sci. 2002; 102(5):513 – 514.

Ozaki Y, Nomura S, Nagahama M, Yoshimura C, Kagawa H, Fukuhara S:Vitamin D receptor genotype and renal disorder in Japanese patients with systemic lupus erythematosis. Nephron 2000; 85(1):86 – 91.

Jafar T, Tripathi G, Mehndi AA, et al.: Vitamin D receptor gene polymorphism in Indian children with idiopathic nephrotic syndrome. Int. J. Hum. Genet. 2009; 9:49 – 55.

Yin F, Liu J, Fan M X, Zhou X and Zhang X: Association between the vitamin D receptor gene polymorphisms and diabetic nephropathy risk: A meta-analysis. Nephrology 2018; 23(2):107 – 116.

Michael F Holick : Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am. J. Clin. Nutr. 2004; 79(3):362-371.

Sakulpipatsin W, Verasertniyom O, Nantiruj K, Totemchokchyakarn K, Lertsrisatit P, Janwityanujit S: Vitamin D receptor gene BsmI polymorphisms in Thai patients with systemic lupus erythematosus. Arthritis Research & Therapy 2006; 8(2):R48.

Published

05-10-2018
Statistics
285 Views | 273 Downloads

How to Cite

Gamila S.M. El-Saeed, Manal F. Elshamaa, Hanan Abdelaziz, Eman A. Elghoroury, Safaa M. Abdelrahman, Dalia A. Abdelhalim, Mona H. Ibrahim, Eman M. Hassan, and Marwa M. Nabhan. “Vitamin D Receptor Gene Polymorphisms in Nephrotic Syndrome Children”. Journal of Innovations in Pharmaceutical and Biological Sciences, vol. 5, no. 4, Oct. 2018, pp. 86-93, doi:10.56511/JIPBS.2018.v5.i04.pp86-93.

Issue

Section

Research Article